Editas Medicine
EDIT
EDIT
256 hedge funds and large institutions have $862M invested in Editas Medicine in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 82 increasing their positions, 67 reducing their positions, and 75 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
36% less capital invested
Capital invested by funds: $1.35B → $862M (-$491M)
59% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 75
Holders
256
Holding in Top 10
–
Calls
$31.2M
Puts
$38.8M
Top Buyers
| 1 | +$41.9M | |
| 2 | +$16M | |
| 3 | +$12.8M | |
| 4 |
CU
CQS (US)
New York
|
+$6.41M |
| 5 |
D.E. Shaw & Co
New York
|
+$5.13M |
Top Sellers
| 1 | -$65.1M | |
| 2 | -$31.3M | |
| 3 | -$31.3M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$29.6M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$14.7M |